2021 annual financial data

Whitehawk Therapeutics 2021 Operating margin

Direct answer

Operating margin was -9,930.09%.

Operating income was -111,217,000 USD and net income was -110,090,000 USD.
Operating cash flow was -22,423,000 USD.

Get free Whitehawk Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
1,120,000 USD
Operating income
-111,217,000 USD
Net income
-110,090,000 USD
Operating cash flow
-22,423,000 USD